The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas

Brucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-speci...

Full description

Bibliographic Details
Main Authors: Ayman Elbehiry, Musaad Aldubaib, Eman Marzouk, Adil Abalkhail, Abdulaziz M. Almuzaini, Mohammed Rawway, Ali Alghamdi, Abdullah Alqarni, Mohammed Aldawsari, Abdelmaged Draz
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/3/654
_version_ 1797608672417808384
author Ayman Elbehiry
Musaad Aldubaib
Eman Marzouk
Adil Abalkhail
Abdulaziz M. Almuzaini
Mohammed Rawway
Ali Alghamdi
Abdullah Alqarni
Mohammed Aldawsari
Abdelmaged Draz
author_facet Ayman Elbehiry
Musaad Aldubaib
Eman Marzouk
Adil Abalkhail
Abdulaziz M. Almuzaini
Mohammed Rawway
Ali Alghamdi
Abdullah Alqarni
Mohammed Aldawsari
Abdelmaged Draz
author_sort Ayman Elbehiry
collection DOAJ
description Brucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-specific manner, making laboratory confirmation of the diagnosis critical to the patient’s recovery. A coordinated strategy for diagnosing and controlling brucellosis throughout the Middle East is required, as this disease cannot be known to occur without reliable microbiological, molecular, and epidemiological evidence. Consequently, the current review focuses on the current and emerging microbiological diagnostic tools for the early detection and control of human brucellosis. Laboratory assays such as culturing, serology, and molecular analysis can frequently be used to diagnose brucellosis. Although serological markers and nucleic acid amplification techniques are extremely sensitive, and extensive experience has been gained with these techniques in the laboratory diagnosis of brucellosis, a culture is still considered to be the “gold standard” due to the importance of this aspect of public health and clinical care. In endemic regions, however, serological tests remain the primary method of diagnosis due to their low cost, user-friendliness, and strong ability to provide a negative prediction, so they are commonly used. A nucleic acid amplification assay, which is highly sensitive, specific, and safe, is capable of enabling rapid disease diagnosis. Patients who have reportedly fully healed may continue to have positive molecular test results for a long time. Therefore, cultures and serological methods will continue to be the main tools for diagnosing and following up on human brucellosis for as long as no commercial tests or studies demonstrate adequate interlaboratory reproducibility. As there is no approved vaccine that prevents human brucellosis, vaccination-based control of animal brucellosis has become an important part of the management of human brucellosis. Over the past few decades, several studies have been conducted to develop <i>Brucella</i> vaccines, but the problem of controlling brucellosis in both humans and animals remains challenging. Therefore, this review also aims to present an updated overview of the different types of brucellosis vaccines that are currently available.
first_indexed 2024-03-11T05:46:51Z
format Article
id doaj.art-34b8e447558a40e894777f28b81c7459
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-11T05:46:51Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-34b8e447558a40e894777f28b81c74592023-11-17T14:19:06ZengMDPI AGVaccines2076-393X2023-03-0111365410.3390/vaccines11030654The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic AreasAyman Elbehiry0Musaad Aldubaib1Eman Marzouk2Adil Abalkhail3Abdulaziz M. Almuzaini4Mohammed Rawway5Ali Alghamdi6Abdullah Alqarni7Mohammed Aldawsari8Abdelmaged Draz9Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi ArabiaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi ArabiaDepartment of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi ArabiaDepartment of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukayriyah 52741, Saudi ArabiaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi ArabiaBiology Department, College of Science, Jouf University, Sakaka 42421, Saudi ArabiaDepartment of Optometry, King Fahad Armed Hospital, Jeddah 23311, Saudi ArabiaDepartment of Family Medicine, King Fahad Armed Hospital, Jeddah 23311, Saudi ArabiaDepartment of Medical services, Ministry of Defense, Riyadh 12426, Saudi ArabiaDepartment of Veterinary Medicine, College of Agriculture and Veterinary Medicine, Qassim University, Buraydah 52571, Saudi ArabiaBrucellosis is considered one of the most serious zoonotic diseases worldwide. This disease affects both human and animal health, in addition to being one of the most widespread zoonotic illnesses in the Middle East and Northern Africa. Human brucellosis generally presents in a diverse and non-specific manner, making laboratory confirmation of the diagnosis critical to the patient’s recovery. A coordinated strategy for diagnosing and controlling brucellosis throughout the Middle East is required, as this disease cannot be known to occur without reliable microbiological, molecular, and epidemiological evidence. Consequently, the current review focuses on the current and emerging microbiological diagnostic tools for the early detection and control of human brucellosis. Laboratory assays such as culturing, serology, and molecular analysis can frequently be used to diagnose brucellosis. Although serological markers and nucleic acid amplification techniques are extremely sensitive, and extensive experience has been gained with these techniques in the laboratory diagnosis of brucellosis, a culture is still considered to be the “gold standard” due to the importance of this aspect of public health and clinical care. In endemic regions, however, serological tests remain the primary method of diagnosis due to their low cost, user-friendliness, and strong ability to provide a negative prediction, so they are commonly used. A nucleic acid amplification assay, which is highly sensitive, specific, and safe, is capable of enabling rapid disease diagnosis. Patients who have reportedly fully healed may continue to have positive molecular test results for a long time. Therefore, cultures and serological methods will continue to be the main tools for diagnosing and following up on human brucellosis for as long as no commercial tests or studies demonstrate adequate interlaboratory reproducibility. As there is no approved vaccine that prevents human brucellosis, vaccination-based control of animal brucellosis has become an important part of the management of human brucellosis. Over the past few decades, several studies have been conducted to develop <i>Brucella</i> vaccines, but the problem of controlling brucellosis in both humans and animals remains challenging. Therefore, this review also aims to present an updated overview of the different types of brucellosis vaccines that are currently available.https://www.mdpi.com/2076-393X/11/3/654zoonotic brucellosishistorydiagnostic approachesvaccine developmentpublic health
spellingShingle Ayman Elbehiry
Musaad Aldubaib
Eman Marzouk
Adil Abalkhail
Abdulaziz M. Almuzaini
Mohammed Rawway
Ali Alghamdi
Abdullah Alqarni
Mohammed Aldawsari
Abdelmaged Draz
The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
Vaccines
zoonotic brucellosis
history
diagnostic approaches
vaccine development
public health
title The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
title_full The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
title_fullStr The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
title_full_unstemmed The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
title_short The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas
title_sort development of diagnostic and vaccine strategies for early detection and control of human brucellosis particularly in endemic areas
topic zoonotic brucellosis
history
diagnostic approaches
vaccine development
public health
url https://www.mdpi.com/2076-393X/11/3/654
work_keys_str_mv AT aymanelbehiry thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT musaadaldubaib thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT emanmarzouk thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT adilabalkhail thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT abdulazizmalmuzaini thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT mohammedrawway thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT alialghamdi thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT abdullahalqarni thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT mohammedaldawsari thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT abdelmageddraz thedevelopmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT aymanelbehiry developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT musaadaldubaib developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT emanmarzouk developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT adilabalkhail developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT abdulazizmalmuzaini developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT mohammedrawway developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT alialghamdi developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT abdullahalqarni developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT mohammedaldawsari developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas
AT abdelmageddraz developmentofdiagnosticandvaccinestrategiesforearlydetectionandcontrolofhumanbrucellosisparticularlyinendemicareas